Efficacy and Safety of Firsekibart in the Treatment of Systemic Sclerosis
Clinical trial NCT07502105 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07502105
- Sponsor
- Tongji Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2027-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.